Last update 02 Aug 2025

US20240158367

Patent Mining

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
HIF-2α
Action
inhibitors
Mechanism
HIF-2α inhibitors(Endothelial PAS domain-containing protein 1 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [5]
Active Indication
Hypertension, PulmonaryInflammatory Bowel DiseasesNeoplasms+ [1]
Inactive Indication-
Originator Organization
Shanghai Jiyu Pharmaceutical Technology Co., Ltd.Shanghai Jiyu Pharmaceutical Technology Co., Ltd.Jiangxi Jemincare Group Co., Ltd.Jiangxi Jemincare Group Co., Ltd.
Active Organization
Jiangxi Jemincare Group Co., Ltd.Jiangxi Jemincare Group Co., Ltd.Shanghai Jiyu Pharmaceutical Technology Co., Ltd.Shanghai Jiyu Pharmaceutical Technology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with US20240158367
Login to view more data
100 Translational Medicine associated with US20240158367
Login to view more data
100 Patents (Medical) associated with US20240158367
Login to view more data
100 Deals associated with US20240158367
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hypertension, PulmonaryDiscovery-
Jiangxi Jemincare Group Co., Ltd.Jiangxi Jemincare Group Co., Ltd.
16 May 2024
Hypertension, PulmonaryDiscovery-
Shanghai Jiyu Pharmaceutical Technology Co., Ltd.Shanghai Jiyu Pharmaceutical Technology Co., Ltd.
16 May 2024
Inflammatory Bowel DiseasesDiscovery-
Shanghai Jiyu Pharmaceutical Technology Co., Ltd.Shanghai Jiyu Pharmaceutical Technology Co., Ltd.
16 May 2024
Inflammatory Bowel DiseasesDiscovery-
Jiangxi Jemincare Group Co., Ltd.Jiangxi Jemincare Group Co., Ltd.
16 May 2024
NeoplasmsDiscovery-
Shanghai Jiyu Pharmaceutical Technology Co., Ltd.Shanghai Jiyu Pharmaceutical Technology Co., Ltd.
16 May 2024
NeoplasmsDiscovery-
Jiangxi Jemincare Group Co., Ltd.Jiangxi Jemincare Group Co., Ltd.
16 May 2024
Von Hippel-Lindau DiseaseDiscovery-
Jiangxi Jemincare Group Co., Ltd.Jiangxi Jemincare Group Co., Ltd.
16 May 2024
Von Hippel-Lindau DiseaseDiscovery-
Shanghai Jiyu Pharmaceutical Technology Co., Ltd.Shanghai Jiyu Pharmaceutical Technology Co., Ltd.
16 May 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free